BNP Paribas Financial Markets’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.56M | Hold |
108,629
| – | – | 0.01% | 1095 |
|
|
2025
Q1 | $9.9M | Buy |
108,629
+49,996
| +85% | +$4.56M | 0.01% | 994 |
|
|
2024
Q4 | $5.06M | Buy |
+58,633
| New | +$5.06M | ﹤0.01% | 1216 |
|
|
2024
Q3 | – | Sell |
-1,800
| Closed | -$165K | – | 3453 |
|
|
2024
Q2 | $165K | Sell |
1,800
-6
| -0.3% | -$549 | ﹤0.01% | 2490 |
|
|
2024
Q1 | $164K | Sell |
1,806
-99,998
| -98% | -$9.07M | ﹤0.01% | 2639 |
|
|
2023
Q4 | $8.28M | Sell |
101,804
-150,004
| -60% | -$12.2M | 0.01% | 755 |
|
|
2023
Q3 | $20.1M | Sell |
251,808
-148,992
| -37% | -$11.9M | 0.03% | 411 |
|
|
2023
Q2 | $31.6M | Buy |
400,800
+300,300
| +299% | +$23.7M | 0.04% | 306 |
|
|
2023
Q1 | $7.8M | Hold |
100,500
| – | – | 0.01% | 742 |
|
|
2022
Q4 | $7.81M | Hold |
100,500
| – | – | 0.01% | 761 |
|
|
2022
Q3 | $6.76M | Buy |
100,500
+50,500
| +101% | +$3.4M | 0.01% | 855 |
|
|
2022
Q2 | $3.84M | Buy |
+50,000
| New | +$3.84M | 0.01% | 963 |
|
|
2021
Q2 | – | Sell |
-200,000
| Closed | -$13.8M | – | 3463 |
|
|
2021
Q1 | $13.8M | Buy |
+200,000
| New | +$13.8M | 0.02% | 489 |
|
|
2020
Q2 | – | Sell |
-100,406
| Closed | -$5.46M | – | 3718 |
|
|
2020
Q1 | $5.46M | Sell |
100,406
-904,000
| -90% | -$49.2M | 0.01% | 667 |
|
|
2019
Q4 | $64.5M | Buy |
1,004,406
+604,406
| +151% | +$38.8M | 0.12% | 78 |
|
|
2019
Q3 | $22.8M | Buy |
+400,000
| New | +$22.8M | 0.04% | 268 |
|